Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2

被引：0

作者：

Reich, Kristian ^{[1
]}

Gordon, Kenneth B. ^{[2
]}

Foley, Peter ^{[3
]}

Lomaga, Mark ^{[4
]}

Han, Chenglong ^{[5
]}

Miller, Megan ^{[6
]}

You, Yin ^{[6
]}

Radtke, Marc Alexander ^{[7
]}

Wu, Jashin J. ^{[8
]}

Armstrong, April W. ^{[9
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[3] Univ Melbourne, St Vincents Hosp Melbourne & Prob Med Res, Skin Hlth Inst, Melbourne, Vic, Australia

[4] DermEdge Res, Mississauga, ON, Canada

[5] Janssen Global Serv LLC, Raritan, NJ USA

[6] Janssen Res & Dev LLC, Raritan, NJ USA

[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[8] Dermatol Res & Educ Fdn, Irvine, CA USA

[9] Univ Southern Calif, Los Angeles, CA 90007 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

28096

引用

页码：AB174 / AB174

页数：1

共 50 条

[41] Effect of apremilast and etanercept on pruritus and health-related quality of life in patients with moderate to severe plaque psoriasis: Results from the LIBERATE study
Green, Lawrence
Thaci, Diamant
Zhang, Zuoshun
Goncalves, Joana
Nograles, Kristine
Nikkels, Arjen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB245 - AB245
[42] Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
Strober, Bruce
Greenberg, Jeffrey D.
Karki, Chitra
Mason, Marc
Guo, Ning
Hur, Peter
Zhao, Yang
Herrera, Vivian
Lin, Feng
Lebwohl, Mark
BMJ OPEN, 2019, 9 (04):
[43] Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
Gordon, K. B.
Gottlieb, A. B.
Langely, R. G.
van de Kerkhof, P.
Belasco, K. T.
Sundaram, M.
Okun, M.
Serra, L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (04) : 767 - 776
[44] Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study
Rubel, D.
Thaci, D.
Blauvelt, A.
Reich, K.
Tsai, T. F.
Vanaclocha, F.
Kingo, K.
Ziv, M.
Pinter, A.
Hugot, S.
You, R.
Augustin, M.
Milutinovic, M.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 71 - 71
[45] Long-term (5-year) maintenance of clinically meaningful improvement in health-related quality of life in patients with moderate to severe Crohn's disease treated with ustekinumab in the IM-UNITI long-term extension study
Sandborn, William J.
Ghosh, Subrata
Han, Chenglong
Gasink, Christopher
Zou, Bin
Feagan, Brian G.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 108 - 109
[46] LONG-TERM (5-YEAR) MAINTENANCE OF CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE TREATED WITH USTEKINUMAB IN THE IM-UNITI LONG-TERM EXTENSION STUDY
Sandborn, William J.
Ghosh, Subrata
Han, Chenglong
Gasink, Christopher
Zou, Bin
Feagan, Brian G.
GASTROENTEROLOGY, 2021, 160 (06) : S558 - S559
[47] Ixekizumab impact on health-related quality of life compared to etanercept and placebo: Results from UNCOVER-2, a phase 3 trial in patients with moderate-to-severe plaque psoriasis
Reich, Kristian
Toth, Darryl
Nikai, Enkeleida
Zhu, Baojin
Carlier, Hilde
Feldman, Steven
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S35 - S35
[48] Malignancy rates and comparisons to the general US population through 3 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis from the VOYAGE 1 and 2 trials
Papp, Kim A.
Reich, Kristian
Gordon, Ken B.
Kimball, Alexa B.
Ramachandran, Paraneedharan
Blauvelt, Andrew
Lebwohl, Mark
Song, Michael
Randazzo, Bruce
Shen, Yaung-Kaung
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB145 - AB145
[49] EFFICACY RESPONSES ACROSS DISEASE SEVERITY AND TREATMENT HISTORY SUBGROUPS OF PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS TREATED WITH GUSELKUMAB: POOLED RESULTS FROM VOYAGE-1 AND VOYAGE-2 THROUGH 5 YEARS
Gordon, K.
Merola, J. F.
Foley, P.
Choi, O.
Chan, D.
Miller, M.
You, Y.
Shen, Y. K.
Yang, Y. W.
Blauvelt, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1842 - 1842
[50] Rapid relief of symptoms and sustained improvement in health related quality of life (HRQOL) in moderate-severe Gastroesophageal reflux disease (GERD) patients treated with pantoprazole
Calleja, JL
Martin, J
Banos, F
Del Val, A
Lanas, A
Dominguez, E
Samchez-Gey, J
GASTROENTEROLOGY, 2003, 124 (04) : A231 - A232

← 1 2 3 4 5 →